|
|
| (131 intermediate revisions by 8 users not shown) |
| Line 1: |
Line 1: |
| − | {{Paris_Saclay}} | + | {{Team:Paris_Saclay/project_header|titre=Human Practices}} |
| | + | <html><style>header{background-image: url("https://static.igem.org/mediawiki/2016/d/d4/T--Paris_Saclay--OverviewBanner.jpg");}</style></html> |
| | | | |
| − | <div class="column full_size">
| + | =Overview= |
| | + | Synthetic biology isn’t easy to explain to non-scientists. But explaining the CRISPR-Cas9 technology is way harder. Not only because those matters are complex, but also because we still do not know precisely the consequences of such technologies. If the CRISPR-Cas9 technology is undoubtedly a revolution, the seism affects other fields, interconnected with science (ethics, law and economy as an example). |
| | | | |
| − | =Human Practices=
| + | As our project use the CRISPR-Cas9 technology, we looked for its potential huge consequences. It seemed important for us to collect the opinion of scientists, politics, patent attorney, but also of general audience. As we worked on the CRISPR-Cas9 technology, we discovered how overwhelming it could be, and ask ourselves how we could imagine a responsible way to work with this technology. |
| | | | |
| − | ==OVERVIEW==
| + | Thus, we tried to find an answer in the concept of responsible research and innovation (RRI). We believe that this concept could help iGEM teams to think about responsibility in their project, and have the strongest link possible between their project and the societal need they want to reach. In other words, we wanted to bring innovation and societal need closer. Considering our project on the CRISPR-Cas9 technology, we believed the concept could give us the good questions we should ask ourselves to build a responsible project. |
| | | | |
| | + | This lead us to investigate about the CRISPR-Cas9 technology and its major consequences in several fields. We tried to draw the consequences and think about what would be a responsible use for scientists but also considering the societal issues. Our Human Practices followed two goals: researching among stakeholders what would be a responsible use, and popularising science for public. To see our researches on the societal issues of the CRISPR/Cas9 technology, click [[Team:Paris_Saclay/HP/Silver|here]]. |
| | | | |
| − | <p> Synthetic biology isn’t easy to explain to non-scientists. But explaining CRISPR-Cas9 is way harder. Not only because those matters are complex, but also because we still don’t know precisely the consequences of such technologies. If CRISPR-Cas 9 is undoubtedly a revolution, the seism affects other fields, interconnected with science (ethics or law as an example). </p>
| + | As there is no general responsible rules than can be applied to all project we developed a "Responsible Research and Innovation test": this test works as a feed-back for each iGEM projects, in order to improve the responsibility in the long term. Thus, we gave this test to iGEM teams from all over the world, and collected their answers, in order to have the best picture of the respect of RRI principles by iGEM teams. |
| | | | |
| − | <p> As our project use CRISPR-Cas9 we looked for its potential huge consequences. It seemed important for us to collect the opinion of both scientists and non scientists. As we worked on CRISPR-Cas9, we discovered how overwhelming it could be, and ask ourselves how we could imagine a responsible way to work with this technology. </p>
| + | A feed-back on the responsibility in a project on the CRISPR-Cas9 technology can give a personal experience about the problematics the project met, and a quick overview on how we could deal with them. To see how we think about the RRI Test, our answer to it, and the answers of iGEM teams all over the world, click [[Team:Paris_Saclay/HP/Gold|here]]. |
| | | | |
| − | <p> Thus, we tried to find an answer in the concept of responsible research and innovation (RRI). We believe that this concept could help iGEM teams to think about responsability in their project. Considering our project on CRISPR-Cas9, we believed the concept could give us the good questions we should ask ourselves to build a responsible project. </p>
| + | See the RRI test: [[Media:T--Paris_Saclay--RRI_Test5.pdf|here]] |
| | | | |
| − | <p> This lead us to investigate about CRISPR-Cas9 and its major consequences in several fields. We tried to draw the consequences and think about what would be a responsible use for scientists but also considering the societal issues. Our Human Practices followed two goals : researching among stakeholders what would be a responsible use, and vulgarisation for public. We met different stakeholders and we made a conference on “The societal issues on CRISPR-Cas9”. This conference in front of students permitted us to vulgarise this new technology. We also met the public as often as we could to explain what was synthetic biology, CRISPR-Cas9, and the issues of it (conference, “Festival vivant”, exhibition in the Nanterre’s university, exhibition in the” pays de Limours”, vox pop). </p>
| + | {{Team:Paris_Saclay/project_footer}} |
| − | | + | |
| − | | + | |
| − | <p> As their is no general responsible rules than can be applied to all project we developed a RRI test : this test works as a feed-back for each iGEM projects, in order to improve the responsability in the long term. </p>
| + | |
| − | | + | |
| − | <p> A feed-back on the responsability in a project on CRISPR-Cas9 can give a personal experience about the problematics the project met, and a quick overview on how we could deal with them. </p>
| + | |
| − | | + | |
| − | <p> See the RRI test : [[RRITest.pdf]] </p>
| + | |
| − | <p> Respond : (typeform) </p>
| + | |
| − | | + | |
| − | Our work on CRISPR-Cas9 had two parts : on the one hand the work with stakeholders, in order to learn more on CRISPR-Cas9, and on the other hand the public engagement we made for popular science, through several activities.
| + | |
| − | | + | |
| − | ==CONFERENCE : THE SOCIETAL ISSUES OF CRISPR-CAS9==
| + | |
| − | | + | |
| − | Because we had a strong concern both on popular science and meeting stakeholders, we hold a conference in our university, in front of students, with two researchers, Jean Denis Faure, a researcher and teacher using CRISPR-Cas9 on plants, and Pierre Walrafen a scientific with a cellular biochemistry and patent engineer. <br>
| + | |
| − | We tried with our guests to think about the societal issues of CRISPR-Cas9, for the ethics, the law and the economy. The ethical problems CRISPR-Cas9 is bringing are huge, and for most of them, unknown. The ethical problems comes with what is done with the technology : therapeutical applications ex vivo or for genetical diseases, or applications on embryos and germ cells. The ethical problems comes along with the question of transhumanism. The issues are rising because of the simplicity of CRISPR-Cas9, authorizing a wider scientific audience to edit the genome. <br>
| + | |
| − | About the legal framework, our speakers made a comparison between the European legal framework, the process based evaluation, and the product based evaluation, and how the patentability was in Europe restrained by a principle of public order.
| + | |
| − | | + | |
| − | ==FESTIVAL VIVANT==
| + | |
| − | | + | |
| − | The “Festival Vivant” is a three days festival, to debate and share views about living organisms and the way we use them. During these three days you could find conferences, workshops and meetings. The iGEM Paris Saclay’s team was there to present the field of synthetic biology and our iJ’AIME project. This festival presented different insights about living organisms to professionals, students and general audience. This festival gave us an other opportunity to do popular science. On this occasion we worked on popularising science : we modeled our project, and presented posters about it.
| + | |
| − | | + | |
| − | ==EXHIBITIONS==
| + | |
| − | The iGEM Paris Saclay 2016 team made an exhibition in Nanterre’s University, a french university that is mostly non-scientific. We made posters, explained to students what was synthetic biology. It was a successful exhibition because the discussion we had with students were very different from discussion from scientific or general audiences !
| + | |
| − | | + | |
| − | Pays de Limours
| + | |
| − | | + | |
| − | ==VOX POP==
| + | |
| − | Our team made a vox pop in a park in Paris, “Les jardins du Luxembourg”. We wanted to know if people ever heard of the field of synthetic biology, and if not spread the field and get their opinion on the subject.<br>
| + | |
| − | What did we learn of this experiments ? Most of the people we met trust scientist to be responsible in their use, and doesn’t feel legitimate to bring a critic on a subject they don’t master. <br>
| + | |
| − | | + | |
| − | ==Meeting stakeholders==
| + | |
| − | | + | |
| − | | + | |
| − | == PARIS-SACLAY MEDIA ==
| + | |
| − | | + | |
| − | Members of our team were interviewed by the magazine of Paris-Saclay, the “Paris-Saclay media”. Paris-Saclay media addresses to all the formation of the university Paris-Saclay : we were very pleased to interviewed because the media follows the interdisciplinarity of the University Paris-Saclay by addressing to all formations, and interdisciplinarity is a major part of the DNA of our team !
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | <br><br><br><br><br><br><br><br>
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | <p>iGEM teams are leading in the area of Human Practices because they conduct their projects within a social/environmental context, to better understand issues that might influence the design and use of their technologies.</p>
| + | |
| − | <p>Teams work with students and advisors from the humanities and social sciences to explore topics concerning ethical, legal, social, economic, safety or security issues related to their work. Consideration of these Human Practices is crucial for building safe and sustainable projects that serve the public interest. </p>
| + | |
| − | <p>For more information, please see the <a href="https://2016.igem.org/Human_Practices">Human Practices Hub</a>.</p>
| + | |
| − | </div>
| + | |
| − | | + | |
| − | | + | |
| − | <div class="column half_size">
| + | |
| − | <div class="highlight">
| + | |
| − | <h5>Note</h5>
| + | |
| − | <p>You must fill out this page in order to be considered for all <a href="https://2016.igem.org/Judging/Awards">awards</a> for Human Practices:</p>
| + | |
| − | <ul>
| + | |
| − | <li>Human Practices silver medal criterion</li>
| + | |
| − | <li>Human Practices gold medal criterion</li>
| + | |
| − | <li>Best Integrated Human Practices award</li>
| + | |
| − | <li>Best Education and Public Engagement award</li>
| + | |
| − | </ul>
| + | |
| − | </div>
| + | |
| − | </div>
| + | |
| − | | + | |
| − | <div class="column half_size">
| + | |
| − | <h5>Some Human Practices topic areas </h5>
| + | |
| − | <ul>
| + | |
| − | <li>Philosophy</li>
| + | |
| − | <li>Public Engagement / Dialogue</li>
| + | |
| − | <li>Education</li>
| + | |
| − | <li>Product Design</li>
| + | |
| − | <li>Scale-Up and Deployment Issues</li>
| + | |
| − | <li>Environmental Impact</li>
| + | |
| − | <li>Ethics</li>
| + | |
| − | <li>Safety</li>
| + | |
| − | <li>Security</li>
| + | |
| − | <li>Public Policy</li>
| + | |
| − | <li>Law and Regulation</li>
| + | |
| − | <li>Risk Assessment</li>
| + | |
| − | </ul>
| + | |
| − | </div>
| + | |
| − | | + | |
| − | | + | |
| − | <div class="column half_size">
| + | |
| − | <h5>What should we write about on this page?</h5>
| + | |
| − | <p>On this page, you should write about the Human Practices topics you considered in your project, and document any special activities you did (such as visiting experts, talking to lawmakers, or doing public engagement).</p>
| + | |
| − | </div>
| + | |
| − | | + | |
| − | | + | |
| − | <div class="column half_size">
| + | |
| − | <h5>Inspiration</h5>
| + | |
| − | <p>Read what other teams have done:</p>
| + | |
| − | <ul>
| + | |
| − | <li><a href="https://2014.igem.org/Team:Dundee/policypractice/experts">2014 Dundee </a></li>
| + | |
| − | <li><a href="https://2014.igem.org/Team:UC_Davis/Policy_Practices_Overview">2014 UC Davis </a></li>
| + | |
| − | <li><a href="https://2013.igem.org/Team:Manchester/HumanPractices">2013 Manchester </a></li>
| + | |
| − | <li><a href="https://2013.igem.org/Team:Cornell/outreach">2013 Cornell </a></li>
| + | |
| − | </ul>
| + | |
| − | </div>
| + | |
